Hepatic Encephalopathy Stage 2

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hepatic Encephalopathy Stage 2 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT06823713

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

The purpose of this study is to assess the safety and efficacy of RTX001 in patients with end-stage liver disease. This study is the first time RTX001, a macrop…

Spain30 participantsStarted 2024-10-15

Treatment: RTX001

All recent trials (10 shown)

TerminatedPhase 2

NCT06987968

A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With…

A Phase 2, Randomized, Controlled, Open-Label, Adaptive Dose Design, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Two Differ…

United States, France, Georgia3 participantsStarted 2025-08-25

Treatment: VS-01 on top of SOC (Active Treatment Group), SOC

Active — Not RecruitingNot Applicable

NCT04315571

Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled E…

For this study, the investigators will be collecting data based on patients' random selection to two different approved standard of care treatments for ascites:…

United States68 participantsStarted 2020-03-24

Treatment: Gore® Viatorr® Endoprosthesis with controlled expansion, Large Volume Paracentesis with albumin infusion

Hepatic Encephalopathy Stage 2

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

All recent trials (10 shown)

A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With…

Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled E…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

All recent trials (10 shown)

A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With…

Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled E…

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy

AST-120 Used to Treat Mild Hepatic Encephalopathy

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy